BioCardia CEO Peter Altman acquires 5,000 common shares valued at $3,900
BCDA•Altman increases direct stake
- BioCardia President, CEO, director Peter Altman bought 5,000 common shares at a weighted average price of $0.78.
- Altman’s direct holding rose to 373,885 shares following the purchase.
